Literature DB >> 15798895

The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases.

S Mahajan1, W M Atkins.   

Abstract

The cytosolic glutathione S-transferases are a family of structurally homologous enzymes with multiple functions, including xenobiotic detoxification, clearance of oxidative stress products, and modulation of cell proliferation and apoptosis signaling pathways. This wide-ranging functional repertoire leads to several possible therapeutic uses for isoform-specific GST inhibitors. These inhibitors may be used, in principle, to modulate tumor cell drug resistance, as sensitizers to therapeutically directed oxidative stress, to enhance cell proliferation and to augment anti-malarial drugs. With increasing knowledge of GST structural and function, rational design strategies and mechanism-based inhibitors have been exploited successfully. However, design of isoform specificity remains a significant challenge in GST inhibitor development. Strategies for further inhibitor design and their possible limitations, along with potential therapeutic uses, are summarized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798895     DOI: 10.1007/s00018-005-4524-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  17 in total

1.  GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis.

Authors:  Mo Wang; Yu Li; Lulu Lin; Guijun Song; Teng Deng
Journal:  Mol Neurobiol       Date:  2015-01-30       Impact factor: 5.590

2.  Nucleophilic catalysis of acylhydrazone equilibration for protein-directed dynamic covalent chemistry.

Authors:  Venugopal T Bhat; Anne M Caniard; Torsten Luksch; Ruth Brenk; Dominic J Campopiano; Michael F Greaney
Journal:  Nat Chem       Date:  2010-05-16       Impact factor: 24.427

Review 3.  The redox biology of schistosome parasites and applications for drug development.

Authors:  Hsin-Hung Huang; Coraline Rigouin; David L Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins.

Authors:  Jana Mladkova; Miloslav Sanda; Eva Matouskova; Irena Selicharova
Journal:  BMC Cancer       Date:  2010-08-23       Impact factor: 4.430

5.  Development of pyrethroid-like fluorescent substrates for glutathione S-transferase.

Authors:  Huazhang Huang; Hongwei Yao; Jun-Yan Liu; Aman I Samra; Shizuo G Kamita; Anthony J Cornel; Bruce D Hammock
Journal:  Anal Biochem       Date:  2012-09-19       Impact factor: 3.365

6.  Comparison of epsilon- and delta-class glutathione S-transferases: the crystal structures of the glutathione S-transferases DmGSTE6 and DmGSTE7 from Drosophila melanogaster.

Authors:  Michele Scian; Isolde Le Trong; Aslam M A Mazari; Bengt Mannervik; William M Atkins; Ronald E Stenkamp
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-09-26

7.  Pleiotropic functions of glutathione S-transferase P.

Authors:  Jie Zhang; Christina Grek; Zhi-Wei Ye; Yefim Manevich; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

8.  Differential scanning fluorometry signatures as indicators of enzyme inhibitor mode of action: case study of glutathione S-transferase.

Authors:  Wendy A Lea; Anton Simeonov
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

9.  Key role for a glutathione transferase in multiple-herbicide resistance in grass weeds.

Authors:  Ian Cummins; David J Wortley; Federico Sabbadin; Zhesi He; Christopher R Coxon; Hannah E Straker; Jonathan D Sellars; Kathryn Knight; Lesley Edwards; David Hughes; Shiv Shankhar Kaundun; Sarah-Jane Hutchings; Patrick G Steel; Robert Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

10.  Altered DNA binding and amplification of human breast cancer suppressor gene BRCA1 induced by a novel antitumor compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)].

Authors:  Korawan Chakree; Chitchamai Ovatlarnporn; Paul J Dyson; Adisorn Ratanaphan
Journal:  Int J Mol Sci       Date:  2012-10-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.